Global Addiction Treatment

Addiction Treatment Comprehensive Study by Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment), Drug Type (Bupropion, Varenicline, Acamprosate, Disulfiram, Naltrexone, Methadone, Buprenorphine, Nicotine Replacement Products), Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center), Distribution Channel (Hospital, Pharmacies, Medical Stores) Players and Region - Global Market Outlook to 2028

Addiction Treatment Market by XX Submarkets | Forecast Years 2023-2028 | CAGR: 6.12%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Addiction Treatment
Addictive disorders are a group of disorders that can cause physical and psychological damage. Receiving treatment is essential for breaking the cycle of addiction. Behavioral therapies help people in drug addiction treatment modify their attitudes and behaviors related to drug use. As a result, patients are able to handle stressful situations and various triggers that might cause another relapse. Addiction is the mental disorder which compels someone repeatedly use substance or engage in behavior even though they have harmful consequences. This treatment is intended to help addicted individual stop compulsive drug seeking and use. The increase in relevance of dependency on psychoses drugs such as alcohol use disorder, opioid additive, Tobacoo, cocaine, marijuana heroine. are driving the growth.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Billion)
CAGR6.12%


The competitive landscape of the addiction treatment market can help stakeholders, including investors, healthcare providers, and policymakers, make informed decisions about how to best address this critical issue.The Players having a strong hold in the market are Cipla Ltd., Allergan plc, Alkermes plc, Pfizer Inc., and Orexo AB. Analyst at AMA Research estimates that Eurpean Players will contribute the maximum growth to Global Addiction Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Cipla Ltd. (India), Allergan plc (Ireland), Alkermes plc (Ireland), Pfizer Inc. (United States), Orexo AB (Sweden), GlaxoSmithKline plc (United Kingdom), Purdue Pharma L.P (United States), Mallinckrodt Pharmaceuticals (United Kingdom), Reckitt Benckiser (United Kingdom) and Teva Pharmaceuticals (Israel) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Forest Laboratories (United States), Indivior PLC (United Kingdom) and Noramco, Inc. (United States).

Segmentation Overview
AMA Research has segmented the market of Global Addiction Treatment market by Type (Alcohol Addiction Treatment, Tobacco/Nicotine Addiction Treatment, Opioid Addiction Treatment and Other Substance Addiction Treatment) and Region.



On the basis of geography, the market of Addiction Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Drug Type, the sub-segment i.e. Bupropion will boost the Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Treatment Center, the sub-segment i.e. Outpatient Treatment Center will boost the Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital will boost the Addiction Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Introduction to Addiction Treatment Drugs with Minimal Side Effects and Growing Demand for Nicotine Addiction Treatments especially Nicotine Gums

Market Growth Drivers:
Assistance to Voluntary Organizations for Prevention of Alcoholism and Drug Abuse and Financial Assistance in the Field of Social Defence

Challenges:
Numerous Side Effects Associated with the Addiction Treatments Drugs and Lack of Awareness and Growing Misconception about addiction treatments from the Underdeveloped Economies

Restraints:
Rising Instances of Misleading Sales Tactics, Deceptive Advertising, and Unethical Marketing Practices and Highly Unregulated Sector of Drug Rehab Vulnerable to many Patients

Opportunities:
Escalating Global Drug or Alcohol Addicted Population and Favorable Government Initiatives related to Addiction Treatment and Drug Development

Market Leaders and their expansionary development strategies
In May 2023, Amulet Capital Partners acquired a majority stake in the addiction treatment provider Promises Behavioral Health for an undisclosed sum. This deal will give Amulet a platform to invest in the high-end addiction treatment market.
In May 2023, the Centers for Medicare and Medicaid Services (CMS) announced that it would cover the cost of medication-assisted treatment (MAT) for opioid use disorder in Medicare beneficiaries. This is a significant step forward in making MAT more accessible to older adults.
According to the United States' SAMHSA (Substance Abuse and Mental Health Services Administration), the United States federal government invests billions of dollars every year into combating drug and alcohol addiction. Much of this is spent on law enforcement, but far more is spent on providing health care and treatment. While there are many different programs, the vast majority of this funding comes from Medicare, Medicaid, Veterans Administration (VA) Benefits, and the Affordable Care Act (ACA), better known as Obamacare. While many rehabs accept government funding.

Key Target Audience
Addiction Treatment Providers, Addiction Treatment Drug Manufacturers, Addiction Treatment Drug Distributors and Traders, Healthcare Industry Associations, Government Agencies, Non-Profit Organizations, Research and Development Institutes and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Alcohol Addiction Treatment
  • Tobacco/Nicotine Addiction Treatment
  • Opioid Addiction Treatment
  • Other Substance Addiction Treatment
By Drug Type
  • Bupropion
  • Varenicline
  • Acamprosate
  • Disulfiram
  • Naltrexone
  • Methadone
  • Buprenorphine
  • Nicotine Replacement Products

By Treatment Center
  • Outpatient Treatment Center
  • Residential Treatment Center
  • Inpatient Treatment Center

By Distribution Channel
  • Hospital
  • Pharmacies
  • Medical Stores

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Assistance to Voluntary Organizations for Prevention of Alcoholism and Drug Abuse
      • 3.2.2. Financial Assistance in the Field of Social Defence
    • 3.3. Market Challenges
      • 3.3.1. Numerous Side Effects Associated with the Addiction Treatments Drugs
      • 3.3.2. Lack of Awareness and Growing Misconception about addiction treatments from the Underdeveloped Economies
    • 3.4. Market Trends
      • 3.4.1. Introduction to Addiction Treatment Drugs with Minimal Side Effects
      • 3.4.2. Growing Demand for Nicotine Addiction Treatments especially Nicotine Gums
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Addiction Treatment, by Type, Drug Type, Treatment Center, Distribution Channel and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Addiction Treatment (Value)
      • 5.2.1. Global Addiction Treatment by: Type (Value)
        • 5.2.1.1. Alcohol Addiction Treatment
        • 5.2.1.2. Tobacco/Nicotine Addiction Treatment
        • 5.2.1.3. Opioid Addiction Treatment
        • 5.2.1.4. Other Substance Addiction Treatment
      • 5.2.2. Global Addiction Treatment by: Drug Type (Value)
        • 5.2.2.1. Bupropion
        • 5.2.2.2. Varenicline
        • 5.2.2.3. Acamprosate
        • 5.2.2.4. Disulfiram
        • 5.2.2.5. Naltrexone
        • 5.2.2.6. Methadone
        • 5.2.2.7. Buprenorphine
        • 5.2.2.8. Nicotine Replacement Products
      • 5.2.3. Global Addiction Treatment by: Treatment Center (Value)
        • 5.2.3.1. Outpatient Treatment Center
        • 5.2.3.2. Residential Treatment Center
        • 5.2.3.3. Inpatient Treatment Center
      • 5.2.4. Global Addiction Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital
        • 5.2.4.2. Pharmacies
        • 5.2.4.3. Medical Stores
      • 5.2.5. Global Addiction Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Addiction Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Cipla Ltd. (India)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Allergan plc (Ireland)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Alkermes plc (Ireland)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Pfizer Inc. (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Orexo AB (Sweden)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. GlaxoSmithKline plc (United Kingdom)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Purdue Pharma L.P (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Reckitt Benckiser (United Kingdom)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Teva Pharmaceuticals (Israel)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Addiction Treatment Sale, by Type, Drug Type, Treatment Center, Distribution Channel and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Addiction Treatment (Value)
      • 7.2.1. Global Addiction Treatment by: Type (Value)
        • 7.2.1.1. Alcohol Addiction Treatment
        • 7.2.1.2. Tobacco/Nicotine Addiction Treatment
        • 7.2.1.3. Opioid Addiction Treatment
        • 7.2.1.4. Other Substance Addiction Treatment
      • 7.2.2. Global Addiction Treatment by: Drug Type (Value)
        • 7.2.2.1. Bupropion
        • 7.2.2.2. Varenicline
        • 7.2.2.3. Acamprosate
        • 7.2.2.4. Disulfiram
        • 7.2.2.5. Naltrexone
        • 7.2.2.6. Methadone
        • 7.2.2.7. Buprenorphine
        • 7.2.2.8. Nicotine Replacement Products
      • 7.2.3. Global Addiction Treatment by: Treatment Center (Value)
        • 7.2.3.1. Outpatient Treatment Center
        • 7.2.3.2. Residential Treatment Center
        • 7.2.3.3. Inpatient Treatment Center
      • 7.2.4. Global Addiction Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital
        • 7.2.4.2. Pharmacies
        • 7.2.4.3. Medical Stores
      • 7.2.5. Global Addiction Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Addiction Treatment: by Type(USD Billion)
  • Table 2. Addiction Treatment Alcohol Addiction Treatment , by Region USD Billion (2017-2022)
  • Table 3. Addiction Treatment Tobacco/Nicotine Addiction Treatment , by Region USD Billion (2017-2022)
  • Table 4. Addiction Treatment Opioid Addiction Treatment , by Region USD Billion (2017-2022)
  • Table 5. Addiction Treatment Other Substance Addiction Treatment , by Region USD Billion (2017-2022)
  • Table 6. Addiction Treatment: by Drug Type(USD Billion)
  • Table 7. Addiction Treatment Bupropion , by Region USD Billion (2017-2022)
  • Table 8. Addiction Treatment Varenicline , by Region USD Billion (2017-2022)
  • Table 9. Addiction Treatment Acamprosate , by Region USD Billion (2017-2022)
  • Table 10. Addiction Treatment Disulfiram , by Region USD Billion (2017-2022)
  • Table 11. Addiction Treatment Naltrexone , by Region USD Billion (2017-2022)
  • Table 12. Addiction Treatment Methadone , by Region USD Billion (2017-2022)
  • Table 13. Addiction Treatment Buprenorphine , by Region USD Billion (2017-2022)
  • Table 14. Addiction Treatment Nicotine Replacement Products , by Region USD Billion (2017-2022)
  • Table 15. Addiction Treatment: by Treatment Center(USD Billion)
  • Table 16. Addiction Treatment Outpatient Treatment Center , by Region USD Billion (2017-2022)
  • Table 17. Addiction Treatment Residential Treatment Center , by Region USD Billion (2017-2022)
  • Table 18. Addiction Treatment Inpatient Treatment Center , by Region USD Billion (2017-2022)
  • Table 19. Addiction Treatment: by Distribution Channel(USD Billion)
  • Table 20. Addiction Treatment Hospital , by Region USD Billion (2017-2022)
  • Table 21. Addiction Treatment Pharmacies , by Region USD Billion (2017-2022)
  • Table 22. Addiction Treatment Medical Stores , by Region USD Billion (2017-2022)
  • Table 23. South America Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 24. South America Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 25. South America Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 26. South America Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 27. South America Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 28. Brazil Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 29. Brazil Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 30. Brazil Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 31. Brazil Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 32. Argentina Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 33. Argentina Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 34. Argentina Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 35. Argentina Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 36. Rest of South America Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 37. Rest of South America Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 38. Rest of South America Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 39. Rest of South America Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 40. Asia Pacific Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 41. Asia Pacific Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 42. Asia Pacific Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 43. Asia Pacific Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 44. Asia Pacific Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 45. China Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 46. China Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 47. China Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 48. China Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 49. Japan Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 50. Japan Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 51. Japan Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 52. Japan Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 53. India Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 54. India Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 55. India Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 56. India Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 57. South Korea Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 58. South Korea Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 59. South Korea Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 60. South Korea Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 61. Taiwan Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 62. Taiwan Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 63. Taiwan Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 64. Taiwan Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 65. Australia Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 66. Australia Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 67. Australia Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 68. Australia Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 69. Rest of Asia-Pacific Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 70. Rest of Asia-Pacific Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 71. Rest of Asia-Pacific Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 72. Rest of Asia-Pacific Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 73. Europe Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 74. Europe Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 75. Europe Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 76. Europe Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 77. Europe Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 78. Germany Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 79. Germany Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 80. Germany Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 81. Germany Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 82. France Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 83. France Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 84. France Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 85. France Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 86. Italy Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 87. Italy Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 88. Italy Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 89. Italy Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 90. United Kingdom Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 91. United Kingdom Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 92. United Kingdom Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 93. United Kingdom Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 94. Netherlands Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 95. Netherlands Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 96. Netherlands Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 97. Netherlands Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 98. Rest of Europe Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 99. Rest of Europe Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 100. Rest of Europe Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 101. Rest of Europe Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 102. MEA Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 103. MEA Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 104. MEA Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 105. MEA Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 106. MEA Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 107. Middle East Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 108. Middle East Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 109. Middle East Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 110. Middle East Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 111. Africa Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 112. Africa Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 113. Africa Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 114. Africa Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 115. North America Addiction Treatment, by Country USD Billion (2017-2022)
  • Table 116. North America Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 117. North America Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 118. North America Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 119. North America Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 120. United States Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 121. United States Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 122. United States Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 123. United States Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 124. Canada Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 125. Canada Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 126. Canada Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 127. Canada Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 128. Mexico Addiction Treatment, by Type USD Billion (2017-2022)
  • Table 129. Mexico Addiction Treatment, by Drug Type USD Billion (2017-2022)
  • Table 130. Mexico Addiction Treatment, by Treatment Center USD Billion (2017-2022)
  • Table 131. Mexico Addiction Treatment, by Distribution Channel USD Billion (2017-2022)
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Company Basic Information, Sales Area and Its Competitors
  • Table 135. Company Basic Information, Sales Area and Its Competitors
  • Table 136. Company Basic Information, Sales Area and Its Competitors
  • Table 137. Company Basic Information, Sales Area and Its Competitors
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Addiction Treatment: by Type(USD Billion)
  • Table 143. Addiction Treatment Alcohol Addiction Treatment , by Region USD Billion (2023-2028)
  • Table 144. Addiction Treatment Tobacco/Nicotine Addiction Treatment , by Region USD Billion (2023-2028)
  • Table 145. Addiction Treatment Opioid Addiction Treatment , by Region USD Billion (2023-2028)
  • Table 146. Addiction Treatment Other Substance Addiction Treatment , by Region USD Billion (2023-2028)
  • Table 147. Addiction Treatment: by Drug Type(USD Billion)
  • Table 148. Addiction Treatment Bupropion , by Region USD Billion (2023-2028)
  • Table 149. Addiction Treatment Varenicline , by Region USD Billion (2023-2028)
  • Table 150. Addiction Treatment Acamprosate , by Region USD Billion (2023-2028)
  • Table 151. Addiction Treatment Disulfiram , by Region USD Billion (2023-2028)
  • Table 152. Addiction Treatment Naltrexone , by Region USD Billion (2023-2028)
  • Table 153. Addiction Treatment Methadone , by Region USD Billion (2023-2028)
  • Table 154. Addiction Treatment Buprenorphine , by Region USD Billion (2023-2028)
  • Table 155. Addiction Treatment Nicotine Replacement Products , by Region USD Billion (2023-2028)
  • Table 156. Addiction Treatment: by Treatment Center(USD Billion)
  • Table 157. Addiction Treatment Outpatient Treatment Center , by Region USD Billion (2023-2028)
  • Table 158. Addiction Treatment Residential Treatment Center , by Region USD Billion (2023-2028)
  • Table 159. Addiction Treatment Inpatient Treatment Center , by Region USD Billion (2023-2028)
  • Table 160. Addiction Treatment: by Distribution Channel(USD Billion)
  • Table 161. Addiction Treatment Hospital , by Region USD Billion (2023-2028)
  • Table 162. Addiction Treatment Pharmacies , by Region USD Billion (2023-2028)
  • Table 163. Addiction Treatment Medical Stores , by Region USD Billion (2023-2028)
  • Table 164. South America Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 165. South America Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 166. South America Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 167. South America Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 168. South America Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 169. Brazil Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 170. Brazil Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 171. Brazil Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 172. Brazil Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 173. Argentina Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 174. Argentina Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 175. Argentina Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 176. Argentina Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 177. Rest of South America Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 178. Rest of South America Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 179. Rest of South America Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 180. Rest of South America Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 181. Asia Pacific Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 182. Asia Pacific Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 183. Asia Pacific Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 184. Asia Pacific Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 185. Asia Pacific Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 186. China Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 187. China Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 188. China Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 189. China Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 190. Japan Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 191. Japan Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 192. Japan Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 193. Japan Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 194. India Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 195. India Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 196. India Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 197. India Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 198. South Korea Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 199. South Korea Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 200. South Korea Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 201. South Korea Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 202. Taiwan Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 203. Taiwan Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 204. Taiwan Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 205. Taiwan Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 206. Australia Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 207. Australia Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 208. Australia Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 209. Australia Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 210. Rest of Asia-Pacific Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 211. Rest of Asia-Pacific Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 212. Rest of Asia-Pacific Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 213. Rest of Asia-Pacific Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 214. Europe Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 215. Europe Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 216. Europe Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 217. Europe Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 218. Europe Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 219. Germany Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 220. Germany Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 221. Germany Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 222. Germany Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 223. France Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 224. France Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 225. France Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 226. France Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 227. Italy Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 228. Italy Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 229. Italy Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 230. Italy Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 231. United Kingdom Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 232. United Kingdom Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 233. United Kingdom Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 234. United Kingdom Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 235. Netherlands Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 236. Netherlands Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 237. Netherlands Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 238. Netherlands Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 239. Rest of Europe Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 240. Rest of Europe Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 241. Rest of Europe Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 242. Rest of Europe Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 243. MEA Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 244. MEA Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 245. MEA Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 246. MEA Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 247. MEA Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 248. Middle East Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 249. Middle East Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 250. Middle East Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 251. Middle East Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 252. Africa Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 253. Africa Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 254. Africa Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 255. Africa Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 256. North America Addiction Treatment, by Country USD Billion (2023-2028)
  • Table 257. North America Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 258. North America Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 259. North America Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 260. North America Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 261. United States Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 262. United States Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 263. United States Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 264. United States Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 265. Canada Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 266. Canada Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 267. Canada Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 268. Canada Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 269. Mexico Addiction Treatment, by Type USD Billion (2023-2028)
  • Table 270. Mexico Addiction Treatment, by Drug Type USD Billion (2023-2028)
  • Table 271. Mexico Addiction Treatment, by Treatment Center USD Billion (2023-2028)
  • Table 272. Mexico Addiction Treatment, by Distribution Channel USD Billion (2023-2028)
  • Table 273. Research Programs/Design for This Report
  • Table 274. Key Data Information from Secondary Sources
  • Table 275. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Addiction Treatment: by Type USD Billion (2017-2022)
  • Figure 5. Global Addiction Treatment: by Drug Type USD Billion (2017-2022)
  • Figure 6. Global Addiction Treatment: by Treatment Center USD Billion (2017-2022)
  • Figure 7. Global Addiction Treatment: by Distribution Channel USD Billion (2017-2022)
  • Figure 8. South America Addiction Treatment Share (%), by Country
  • Figure 9. Asia Pacific Addiction Treatment Share (%), by Country
  • Figure 10. Europe Addiction Treatment Share (%), by Country
  • Figure 11. MEA Addiction Treatment Share (%), by Country
  • Figure 12. North America Addiction Treatment Share (%), by Country
  • Figure 13. Global Addiction Treatment share by Players 2022 (%)
  • Figure 14. Global Addiction Treatment share by Players (Top 3) 2022(%)
  • Figure 15. Global Addiction Treatment share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Cipla Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 18. Cipla Ltd. (India) Revenue: by Geography 2022
  • Figure 19. Allergan plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 20. Allergan plc (Ireland) Revenue: by Geography 2022
  • Figure 21. Alkermes plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 22. Alkermes plc (Ireland) Revenue: by Geography 2022
  • Figure 23. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 24. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 25. Orexo AB (Sweden) Revenue, Net Income and Gross profit
  • Figure 26. Orexo AB (Sweden) Revenue: by Geography 2022
  • Figure 27. GlaxoSmithKline plc (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 28. GlaxoSmithKline plc (United Kingdom) Revenue: by Geography 2022
  • Figure 29. Purdue Pharma L.P (United States) Revenue, Net Income and Gross profit
  • Figure 30. Purdue Pharma L.P (United States) Revenue: by Geography 2022
  • Figure 31. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 32. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2022
  • Figure 33. Reckitt Benckiser (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 34. Reckitt Benckiser (United Kingdom) Revenue: by Geography 2022
  • Figure 35. Teva Pharmaceuticals (Israel) Revenue, Net Income and Gross profit
  • Figure 36. Teva Pharmaceuticals (Israel) Revenue: by Geography 2022
  • Figure 37. Global Addiction Treatment: by Type USD Billion (2023-2028)
  • Figure 38. Global Addiction Treatment: by Drug Type USD Billion (2023-2028)
  • Figure 39. Global Addiction Treatment: by Treatment Center USD Billion (2023-2028)
  • Figure 40. Global Addiction Treatment: by Distribution Channel USD Billion (2023-2028)
  • Figure 41. South America Addiction Treatment Share (%), by Country
  • Figure 42. Asia Pacific Addiction Treatment Share (%), by Country
  • Figure 43. Europe Addiction Treatment Share (%), by Country
  • Figure 44. MEA Addiction Treatment Share (%), by Country
  • Figure 45. North America Addiction Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Cipla Ltd. (India)
  • Allergan plc (Ireland)
  • Alkermes plc (Ireland)
  • Pfizer Inc. (United States)
  • Orexo AB (Sweden)
  • GlaxoSmithKline plc (United Kingdom)
  • Purdue Pharma L.P (United States)
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Reckitt Benckiser (United Kingdom)
  • Teva Pharmaceuticals (Israel)
Additional players considered in the study are as follows:
Forest Laboratories (United States) , Indivior PLC (United Kingdom) , Noramco, Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 224 Pages 65 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Addiction Treatment Quantitative research analysis
Global Addiction Treatment Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Cipla Ltd. (India), Allergan plc (Ireland), Alkermes plc (Ireland), Pfizer Inc. (United States), Orexo AB (Sweden), GlaxoSmithKline plc (United Kingdom), Purdue Pharma L.P (United States), Mallinckrodt Pharmaceuticals (United Kingdom), Reckitt Benckiser (United Kingdom) and Teva Pharmaceuticals (Israel) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Introduction to Addiction Treatment Drugs with Minimal Side Effects " is seen as one of major influencing trends for Addiction Treatment Market during projected period 2022-2028.
The Addiction Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.
Analysts at AMA estimates Addiction Treatment Market to reach USD6.51 Billion by 2028.

Know More About Global Addiction Treatment Report?

Have a Query? Click Here

Other Related Reports

Atopic Dermatitis Treatment Comprehensive Study by Route of Administration (Oral, Topical, Injectable), Treatment (Medications, Wet Dressings, Light Therapy, Others), Distribution Channel (Hospital P...
$ 3750
Axial Spondyloarthritis Treatment Comprehensive Study by Type (COX-2 Antagonists, COX Inhibitors, Others), Application (Hospital, Rehabilitation Center, Other), Distribution Channel (Online, Medical ...
$ 3650
Carotid Endarterectomy Comprehensive Study by Application (Hospitals, Clinics, Ambulatory Surgical Centre, Others), Diagnosis (Computed Tomography Angiography, Carotid Ultrasound, Magnetic Resonance ...
$ 3500
Wilson's Disease Treatment Comprehensive Study by Type (Medication (Trientine, Penicillamine, Zinc Acatate), Surgery), Application (Hospitals, Specialty Clinics, Diagnostic Laboratories), Test Type (...
$ 3750
Myelodysplastic Syndrome Comprehensive Study by Type (Alkylating Agents, Cytotoxic Antibiotics, Topoisomerase Inhibitors, Others), Application (Hospital, Clinic), Route of Administration (Generic, Or...
$ 3650
Vertebral Compression Fracture Devices Comprehensive Study by Type (Balloon Kyphoplasty Devices, Vertebroplasty Devices), Surgery Type (Open Spine Surgery, Minimally Invasive Spine Surgery, Lumbar Fu...
$ 3650